Cargando…

Symptomatic Myocarditis Post COVID-19 Vaccination

There are few major adverse events after the coronavirus disease 2019 (COVID-19) vaccination. However, increasing cases of myocarditis and pericarditis are being reported to the Vaccine Adverse Event Reporting System (VAERS) in young people, primarily after the second dose of messenger RNA (mRNA) CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Palak, Desai, Dhaval, Ganta, Nagapratap, Tadepalli, Satish, Kata, Priyaranjan, Kanukuntla, Anish, Schoenfeld, Matthew, Sathya, Bharath, Okere, Arthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095512/
https://www.ncbi.nlm.nih.gov/pubmed/35573513
http://dx.doi.org/10.7759/cureus.24052
_version_ 1784705769399123968
author Patel, Palak
Desai, Dhaval
Ganta, Nagapratap
Tadepalli, Satish
Kata, Priyaranjan
Kanukuntla, Anish
Schoenfeld, Matthew
Sathya, Bharath
Okere, Arthur
author_facet Patel, Palak
Desai, Dhaval
Ganta, Nagapratap
Tadepalli, Satish
Kata, Priyaranjan
Kanukuntla, Anish
Schoenfeld, Matthew
Sathya, Bharath
Okere, Arthur
author_sort Patel, Palak
collection PubMed
description There are few major adverse events after the coronavirus disease 2019 (COVID-19) vaccination. However, increasing cases of myocarditis and pericarditis are being reported to the Vaccine Adverse Event Reporting System (VAERS) in young people, primarily after the second dose of messenger RNA (mRNA) COVID-19 vaccines. We present a case series of myopericarditis post mRNA (Moderna) and myocarditis post vector-based (Johnson & Johnson) COVID-19 vaccines. We intend to highlight the importance of early diagnosis and treatment of vaccine-related myocarditis to reduce mortality and morbidity. 
format Online
Article
Text
id pubmed-9095512
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-90955122022-05-14 Symptomatic Myocarditis Post COVID-19 Vaccination Patel, Palak Desai, Dhaval Ganta, Nagapratap Tadepalli, Satish Kata, Priyaranjan Kanukuntla, Anish Schoenfeld, Matthew Sathya, Bharath Okere, Arthur Cureus Cardiology There are few major adverse events after the coronavirus disease 2019 (COVID-19) vaccination. However, increasing cases of myocarditis and pericarditis are being reported to the Vaccine Adverse Event Reporting System (VAERS) in young people, primarily after the second dose of messenger RNA (mRNA) COVID-19 vaccines. We present a case series of myopericarditis post mRNA (Moderna) and myocarditis post vector-based (Johnson & Johnson) COVID-19 vaccines. We intend to highlight the importance of early diagnosis and treatment of vaccine-related myocarditis to reduce mortality and morbidity.  Cureus 2022-04-11 /pmc/articles/PMC9095512/ /pubmed/35573513 http://dx.doi.org/10.7759/cureus.24052 Text en Copyright © 2022, Patel et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Patel, Palak
Desai, Dhaval
Ganta, Nagapratap
Tadepalli, Satish
Kata, Priyaranjan
Kanukuntla, Anish
Schoenfeld, Matthew
Sathya, Bharath
Okere, Arthur
Symptomatic Myocarditis Post COVID-19 Vaccination
title Symptomatic Myocarditis Post COVID-19 Vaccination
title_full Symptomatic Myocarditis Post COVID-19 Vaccination
title_fullStr Symptomatic Myocarditis Post COVID-19 Vaccination
title_full_unstemmed Symptomatic Myocarditis Post COVID-19 Vaccination
title_short Symptomatic Myocarditis Post COVID-19 Vaccination
title_sort symptomatic myocarditis post covid-19 vaccination
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095512/
https://www.ncbi.nlm.nih.gov/pubmed/35573513
http://dx.doi.org/10.7759/cureus.24052
work_keys_str_mv AT patelpalak symptomaticmyocarditispostcovid19vaccination
AT desaidhaval symptomaticmyocarditispostcovid19vaccination
AT gantanagapratap symptomaticmyocarditispostcovid19vaccination
AT tadepallisatish symptomaticmyocarditispostcovid19vaccination
AT katapriyaranjan symptomaticmyocarditispostcovid19vaccination
AT kanukuntlaanish symptomaticmyocarditispostcovid19vaccination
AT schoenfeldmatthew symptomaticmyocarditispostcovid19vaccination
AT sathyabharath symptomaticmyocarditispostcovid19vaccination
AT okerearthur symptomaticmyocarditispostcovid19vaccination